Inhibition of transcription factor NFAT activity in activated platelets enhances their aggregation and exacerbates gram-negative bacterial septicemia

Valentina Poli
Harvard Medical School
December 20, 2021
Immunity
https://pubmed.ncbi.nlm.nih.gov/34995475

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/34995475

Research summary

This study investigates how NFAT transcription factors in platelets regulate immune and thrombotic responses during sepsis. Using the iNFATuation mouse model, the authors showed that platelet-specific inhibition of NFAT increases platelet aggregation, promotes neutrophil extracellular trap (NET) formation, and worsens outcomes in gram-negative septicemia.

Key outcome of the study

NFAT inhibition in platelets leads to excessive aggregation and immune activation, exacerbating sepsis, and revealing a non-transcriptional regulatory role for NFAT in platelets.

Model

iNFATuation mouse model with Cre-inducible expression of VIVIT peptide inserted into the Rosa26 locus using FLEx technology; activated in platelets via Pf4-Cre.

TARGET:
Nfatc1, Nfatc2, Nfatc3, Nfatc4
Synonyms:
NFAT1, NFAT2, NFAT3, NFAT4

Keywords

Sepsis, Platelet activation, NFAT signaling, Inflammation, NETs, Thrombosis

Technical specifications

Knockin, Rosa26 locus, FLEx technology, Cre-inducible, Platelet-specific expression, VIVIT peptide

Related products

Catalogue product

No items found.

Customized product

No items found.

Catalogue product

No items found.
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe